DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $594,987,466 | +112.2% | 2,402,654 | +105.2% | 1.33% | +17.9% |
| Q2 2023 | $280,451,280 | +1.7% | 1,170,675 | +6.8% | 1.13% | -2.2% |
| Q1 2023 | $275,855,260 | +30.5% | 1,096,618 | +37.4% | 1.15% | +21.8% |
| Q4 2022 | $211,435,695 | +12.9% | 798,196 | +9.8% | 0.95% | -1.8% |
| Q3 2022 | $187,313,000 | +0.6% | 726,632 | -1.0% | 0.96% | +6.2% |
| Q2 2022 | $186,104,000 | +3.4% | 734,081 | +19.7% | 0.91% | +21.9% |
| Q1 2022 | $179,934,000 | -9.1% | 613,420 | +2.0% | 0.74% | +2.8% |
| Q4 2021 | $197,938,000 | -46.9% | 601,617 | -50.9% | 0.72% | -52.7% |
| Q3 2021 | $372,696,000 | +9.5% | 1,224,201 | -3.5% | 1.53% | +2.0% |
| Q2 2021 | $340,292,000 | +25.9% | 1,268,042 | +5.6% | 1.50% | +8.5% |
| Q1 2021 | $270,207,000 | +1.9% | 1,200,493 | +0.5% | 1.38% | -18.1% |
| Q4 2020 | $265,267,000 | +0.9% | 1,194,145 | -2.2% | 1.69% | -26.6% |
| Q3 2020 | $262,845,000 | +14.8% | 1,220,661 | -5.8% | 2.30% | -2.1% |
| Q2 2020 | $229,054,000 | +19.1% | 1,295,332 | -6.7% | 2.35% | -8.1% |
| Q1 2020 | $192,258,000 | -12.9% | 1,389,048 | -3.4% | 2.56% | +3.9% |
| Q4 2019 | $220,697,000 | +8.2% | 1,437,954 | +1.8% | 2.46% | -7.3% |
| Q3 2019 | $204,019,000 | -13.3% | 1,412,582 | -14.2% | 2.66% | -13.1% |
| Q2 2019 | $235,396,000 | +6.9% | 1,647,046 | -1.2% | 3.06% | +0.9% |
| Q1 2019 | $220,180,000 | +9.7% | 1,667,776 | -14.3% | 3.03% | -7.3% |
| Q4 2018 | $200,644,000 | -3.5% | 1,945,732 | +1.6% | 3.27% | +9.5% |
| Q3 2018 | $207,993,000 | – | 1,914,166 | – | 2.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |